InflaRx (IFRX) Price to Book (2017 - 2026)
InflaRx's (IFRX) quarterly Price to Book came in at 0.95 in Q2 2026, up 31.25% year-over-year from 0.73 in Q2 2025, and down 36.03% quarter-over-quarter from 1.49 in Q1 2026.
Analysis
InflaRx (IFRX) Price to Book (2017 - 2026) Analysis & Trends
InflaRx has disclosed Price to Book across 10 years of filings, most recently posting 0.95 for Q2 2026.
- In Q2 2026, Price to Book rose 31.25% year-over-year to 0.95; the TTM figure through Jun 2026 stood at 0.95 (up 31.25% YoY), while the FY2025 annual figure was 1.56, down 30.38% from the prior year.
- Price to Book came in at 0.95 for Q2 2026 at InflaRx, down from 1.49 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 2.23 in Q4 2024 to a low of 0.59 in Q2 2022.
- Average Price to Book over 5 years is 1.17, with a median of 1.1 recorded in 2023.
- Year-over-year, Price to Book slumped 43.44% in 2023 and surged 156.87% in 2024.
- Over 5 years, Price to Book stood at 1.54 in 2022, then tumbled by 43.44% to 0.87 in 2023, then surged by 156.87% to 2.23 in 2024, then plunged by 32.43% to 1.51 in 2025, then sank by 36.86% to 0.95 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 0.95 in Q2 2026, 1.49 in Q1 2026, and 1.51 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.95 |
| Mar 31, 2026 | 1.49 |
| Dec 31, 2025 | 1.51 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.82 |
| Dec 31, 2024 | 2.23 |
| Sep 30, 2024 | 1.26 |
| Jun 30, 2024 | 1.16 |
| Mar 31, 2024 | 0.88 |
| Dec 31, 2023 | 0.87 |
| Sep 30, 2023 | 1.04 |
| Jun 30, 2023 | 1.47 |
| Mar 31, 2023 | 1.03 |
| Dec 31, 2022 | 1.54 |
| Sep 30, 2022 | 1.16 |
| Jun 30, 2022 | 0.59 |
| Mar 31, 2022 | 0.76 |
| Dec 31, 2021 | 1.75 |
| Sep 30, 2021 | 0.54 |